Skip to main content
Clinical Trials/NCT03962075
NCT03962075CompletedNot Applicable

Short-term Outcomes of Laparoscopic Repair of Paravaginal Defects: A Clinical Trial

Zagazig University0 sites50 target enrollmentStarted: August 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Primary Endpoint
post-operative hematuria

Study Overview

Brief Summary

this study designed To evaluate the efficacy and outcomes of laparoscopic approach for repair of paravaginal defects associated with anterior vaginal wall prolapse.

Detailed Description

This prospective interventional study. designed to evaluate the efficacy and outcomes of laparoscopic approach for repair of paravaginal defects associated with anterior vaginal wall prolapse .fifty participants with cystocele of lateral type offered laparoscopic paravaginal repair. the investigator used a 10mm laparoscope, with video camera, was introduced through the umbilical trocar. Another 5 mm in suprapubic area and two 10 mm trocars in right and left lateral abdominal sides were introduced. The larger trocar was needed to accommodate the passage of needles into the abdomen. Spacing of trocars sufficiently from each other was needed to facilitate laparoscopic suturing. Transperitoneal approach to retropubic space was used. Two to four polypropylene sutures were applied on each side. Sutures were tied with intracorporeal . The study evaluated the following outcomes Operative time, intra-operative blood loss, hospital stay , post-operative urinary symptoms, post-operative pain, fever, haematuria, post-operative vaginal wall prolapse .

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • female patient with cystocele of lateral type ( paravaginal defect )

Exclusion Criteria

  • previous retropubic surgery,
  • uterine prolapse,
  • stress urinary incontinence or
  • morbid obesity

Arms & Interventions

laparoscopic paravaginal repair

Other

patient enrolled in this arm were offered laparoscopic paravaginal repair by Using a 10mm laparoscope, video camera, was introduced through the umbilical trocar. Another 5 mm in suprapubic area and two 10 mm trocars in right and left lateral abdominal sides were introduced. The larger trocar was needed to accommodate the passage of needles into the abdomen. Spacing of trocars sufficiently from each other was needed to facilitate laparoscopic suturing. Transperitoneal approach to retropubic space was used. Two to four polypropylene sutures were applied on each side. Sutures were tied with intracorporeal technique All cases received diclofenac potassium 100 mg and meperidine hydrochloride 50 mg intramuscular with anesthesia recovery and 12 hours later second dose of diclofenac potassium was given. Also 40-60 mg Enoxaparin was given 6-12 hours postoperatively as subcutaneous injection.

Foley's catheter was removed 6 hours postoperative

Intervention: laparoscopic paravaginal repair (Procedure)

Outcomes

Primary Outcomes

post-operative hematuria

Time Frame: starts observation of urine 1hour after end of operation - ends 24 hours after the starting observation

visible red or brown discoloration of urine .

fever

Time Frame: starts after shifting the patient from the recovery room to inpatient ward - end 24 hours after shifting the patient

body temperature 38 Celsius or above

operative time

Time Frame: insertion of the primary tracer ( umbilical trocar )-during the procedure - ends with removing camera telescope

time needed for the procedure to be completed

intraoperative blood loss

Time Frame: start with dissection or retropubic space - during the procedure -ends with removing the camera telescope at the end of operation

amount of bleeding during the procedure

post-operative pain: Faces Pain Scale

Time Frame: start after patient recovery from anaesthesia - ends after 12 hours

assessment of pain using Faces Pain Scale( displaying faces that show how much pain the participant can feel. starting with the face on far left shows no pain as The faces move to the right show more and more pain that ends with the face on the right which shows the worst pain then the participants Point to the face that shows how much they feel pain , Each face has a score 0, 2, 4, 6, 8, or 10, so score "0" = "no pain" and score "10" = "very much pain).

hospital stay

Time Frame: during hospitalization

hours needed to keep the patient in hospital post operative

Secondary Outcomes

  • post-operative vaginal wall prolapse(starts one week following the procedure - three months after the procedure - six months after the procedure -ends one year after the procedure)
  • post-operative abnormal urinary symptoms(starts one week following the procedure - three months after the procedure - six months after the procedure -ends one year after the procedure)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Hossam mohamed

principal investigator

Zagazig University

Similar Trials